In addition, in women with current osteoporosis, MMP-9 levels decreased significantly after the introduction of bone-protective factors into their lifestyle in the form of regular 3-month balanced training [121] or therapeutic treatment with three different compounds: alendronate, risedronate, and ralocifene [122]. Here, MMP9 is linked to osteoporosis.